Feature | October 04, 2013

Latest IMV Market Report Shows Increased Cath Lab Purchase Activity Over Next Three Years

Cath lab IMV market report

October 4, 2013 — Purchasing activity for cardiac catheterization labs in the United States appears to be growing as more healthcare facilities look to replace aging equipment, according to a new report by IMV Medical Information Division. The census-based report finds that both patient volume and installed base are rising as the market recovers from a recent slowdown.

According to the report, patient volume has increased at a rate of 0.5 percent per year, and the number of identified fixed cath lab systems has increased at an average annual growth rate of 3.3 percent, from 4,225 units as of IMV’s 2008 census to 4,980 units in 2012. Going forward, an estimated 44 percent of surveyed cath lab sites are considering the purchase of cath lab units over the next three years to replace units or add rooms. This is likely due to several factors, including:

· An installed base of older units. The average replacement cycle is 11.1 years for sites that are planning to replace their units, which is up from 10 years in 2008. While cath lab facilities are holding on to their units longer, the peak years of cath lab installations occurred about a decade ago, so sites are replacing a larger number of aging units.

· Continued innovation and interest in using the cath lab rooms for minimally invasive procedures, including noncardiac procedures such as carotid, iliac, femoral, runoff, renal and extremity studies. Since 2000, the proportion of cath lab rooms being used for noncardiac cases has increased from 47 percent to 67 percent of rooms. In addition to diagnostic cardiologists and interventional radiologists, cardiothoracic surgeons and endovascular/vascular surgeons are performing procedures in cath lab settings.

· More than one-third of purchase plans are for adding fixed C-arms for use with cardiac and noncardiac procedures. In addition to adding units to the traditional cath lab or cardiology suites, at least 7 percent of sites are planning to locate their additional units in surgery/operating room (OR) departments.

An estimated 3.82 million patient cases were performed at 2,100 cardiac cath lab sites in 2012, including both cardiac and noncardiac patient cases. During the past decade, the total volume of patient cases peaked in 2006 at 4.21 million and declined to a low of 3.75 million in 2008. Since 2009, total patient volume has been relatively stable, increasing at an average annual growth rate of 0.5 percent.

“This slowdown in patient cases handled by cath labs is due to the convergence of several factors,” observed Lorna Young, senior director, Market Research at IMV. “With the advent of CT coronary angiography procedures (CTA), the volume of diagnostic cath procedures appears to have declined. In addition, the increased use of preauthorization policies by third party insurers may be at play.”

For more information: www.imvinfo.com

Related Content

Sci-image, Scimage, CVIS, CIIMS, Cpacs c-pacs, cardiovascular information system

Today's cardiovascular information systems need to incorporate all facets of the cardiology department, including subspecialties, to allow a complete picture of a patient's record. These data also need to be able to be shared with enterprise data systems, such as the electronic medical record (EMR). This image is from ScImage, illustrating the various aspects that integrate to make up a complete CVIS. 

 

Feature | September 29, 2016 | Val Kapitula, RT(R), PMP, CIIP
Cardiovascular Information and Imaging Systems (CVIS) have existed for many years in the dedicated sub-specialty area
Keystone Heart, TriGuard Embolic Protection Device, real-world results, PCR London Valves Conference 2016
News | Embolic Protection Devices| September 29, 2016
Keystone Heart Ltd. recently announced the safety and efficacy of the TriGuard Cerebral Embolic Protection device...
Neuravi, EmboTrap II stent retriever, thrombectomy device, acute stroke, European launch, CE Mark
News | Thrombectomy Devices| September 28, 2016
Neuravi recently announced Conformité Européenne (CE) Mark approval and launch of the company’s newly available...
Infinix 4D CT

Toshiba's Infinix 4D CT, which combines CT with angiography in the interventional lab.

Feature | Angiography| September 28, 2016 | Tom Watson BS, RCVT, Clinical Analyst, MD Buyline
One of the more significant advancements for interventional X-ray (IXR) in the past few years has been a significantl
TCT 2016, TCT.16, main arena, late breaking trials
Feature | Cath Lab| September 28, 2016
September 28, 2016 — The Cardiovascular Research Foundation (CRF) has announced the 11 late-breaking trials and 16 fi
Avinger, U.S. Department of Veterans Affairs, VA, Lumivascular technology, FSS Contract Award
News | Optical Coherence Tomography (OCT)| September 27, 2016
Avinger Inc. recently announced the company has received an FSS Contract Award from the U.S. Department of Veterans...
Bard, Lutonix 014 DCB, drug-coated balloon, six-month endpoint, FDA IDE trial
Technology | Drug-Eluting Balloons| September 26, 2016
C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption (IDE...
smartphones, hospital tranfers, heart attack patients, JACC study, South Korea
News | Mobile Devices| September 23, 2016
Smartphone communication among medical teams at different hospitals can significantly reduce the time it takes for...
Robert M. Califf, FDA commissioner, future of cardiovascular medicine, JACC column
News | Business| September 23, 2016
Technology advances coupled with increased use of social media and personal devices could offer new possibilities for...
Medtronic, In.Pact Admiral drug-coated balloon, trial data, VIVA
News | Drug-Eluting Balloons| September 22, 2016
New data presented at the Vascular Interventional Advances (VIVA) conference demonstrated the durability, consistency...
Overlay Init